MEDICAL RADIOLOGICAL DEFENSE (ATD)
Abstract
This project (TR3) funds advanced technology development of medical countermeasures against radiological exposure. Specifically, innovative technical approaches will be used to develop, refine, and transition promising products to advanced development efforts to mitigate health consequences resulting from Acute Radiation Exposure (ARS) and Delayed Effects of Acute Radiation Exposure (DEARE). Promising products and pertinent science and technology data will be used to support Investigational New Drug (IND) applications and Food and Drug Administration (FDA) licensure processes, with an emphasis on the development of pretreatments to protect military responders in the event of a radiological incident. Research efforts and data are collaboratively shared with other government agencies so that more mature and promising product candidates will be quickly transitioned to advanced development efforts. In FY13, all research in this Project (TR3) is realigned to Project TM3 - Techbase Medical Defense (ATD).
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2013
- Source ID
- TR3_0603384BP_3_0400_PB_2013
Related Documents
- Root: CHEMICAL/BIOLOGICAL DEFENSE (ATD)
- Child Accomplishment: 1) Radiological Medical Countermeasures